PEP's Q2 revenues rose 1% to $22.73 billion, beating estimates despite a 7% drop in core EPS to $2.12. Global momentum and better North America execution drove 2.1% organic revenue growth in Q2. PEP ...
Raises FY24 GAAP EPS view to approximately $3.92-$3.96 from approximately $3.88-$3.98. Raises FY24 transaction margin dollar view to mid single digit growth from low to mid single digit growth. Now ...
PVH Corp. PVH reported second-quarter fiscal 2024 results, wherein both earnings and revenues topped the Zacks Consensus Estimate. The bottom line significantly improved while the top line fell year ...
McKesson Corporation MCK reported first-quarter fiscal 2026 adjusted earnings per share (EPS) of $8.26, which beat the Zacks Consensus Estimate of $8.23 by 0.4%. The bottom line improved 4.8% on a ...
Gilead Sciences, Inc. GILD reported first-quarter 2026 adjusted earnings per share (EPS) of $2.03, which beat the Zacks Consensus Estimate of $1.89. In the year-ago quarter, the company reported an ...
Based on page view growth over the last 3 trading days Key Takeaways CVS posted Q2 adjusted EPS of $1.81, beating estimates despite a 1.1% year-over-year decline. CVS' revenues rose 8.4% to $98.91B, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results